Johan Richter

Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial

Johan Richter, Joëlle Guilhot, Franz Gruber et al. · The Lancet Oncology · 2018 · 587 citations · Full text

Hematological Malignancy, Medicine, Chronic Myeloid Leukaemia +10

Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Andreas Hochhaus, Gianantonio Rosti, F-X Mahon et al. · Annals of Oncology · 2017 · 331 citations

Hematological Malignancy, Oncology, Chronic Myeloid Leukaemia +8

Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia

Mette Ilander, Ulla Olsson‐Strömberg, Heinrich Schlums et al. · Leukemia · 2016 · 239 citations · Full text

Success Story of Targeted Therapy in Chronic Myeloid Leukemia: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2008

Magnus Björkholm, Lotta Ohm, Sandra Eloranta et al. · Journal of Clinical Oncology · 2011 · 213 citations

Murine models of acute neuronopathic Gaucher disease

Ida Enquist, Christophe Lo Bianco, Andreas Ooka et al. · Proceedings of the National Academy of Sciences · 2007 · 195 citations · Full text

Genetics, Cell Death, Alzheimer's Disease +18